How Pharmacists Could Be Key to Addressing the Opioid Crisis
Optimal adherence to long-acting injectable buprenorphine (BUP-XR or Sublocade®) for opioid use disorder saves $15,017 per patient annually by drastically reducing costly emergency department visits and detoxification events. This research supports the economic benefits of paying community pharmacists to administer long-acting injections, effectively improving treatment access while lowering overall healthcare spending.
Bridging the Knowledge Gap: Why ECHO Idaho is a Game-Changer for Idaho Clinicians
A recent update from the University of Idaho highlights the critical role of Project ECHO Idaho in equipping healthcare providers with the tools to manage these evolving challenges. For pharmacists interested in delivering low-barrier MOUD care, this program offers a unique, no-cost pathway to expertise.
Landmark Support for Pharmacist-Prescribed Buprenorphine in Minnesota
Landmark Support for Pharmacist-Prescribed Buprenorphine in Minnesota
In a major win for low-barrier access to Medications for Opioid Use Disorder (MOUD), the Minnesota Medical Association (MMA) Board of Trustees recently voted unanimously to support legislative efforts that would allow appropriately trained pharmacists to independently initiate, prescribe, and administer buprenorphine.
No Payment, No Program: What the 2025 Medicaid Summit Means for Pharmacy-Based OUD Treatment
Establishing a sustainable model for pharmacist-led clinical services requires more than just clinical expertise—it requires a framework for reimbursement. Based on the fundamental pillars of Infrastructure, Collaboration, and Dedicated Time, this guide explores how pharmacists can successfully navigate Medicaid payment structures.
By aligning these three areas, pharmacies can transition from a product-centered model to a service-oriented one that prioritizes patient outcomes and professional sustainability.
Study Shows Telehealth Removes Key Obstacles in OUD Care, but Pharmacy Barriers Persist
Telehealth is Transforming Access to OUD Care.